Colorectal Carcinoma Biomarker Panel

Summary

  • Description: Key testing to further characterise colon cancer for more personalised treatment
  • Sample Type: Tissue Block (FFPE)
  • Requirements: Doctor’s request form and histology report
  • TAT: 4-6 Weeks
  • Analytical Lab: CAP/NABL reference lab (India)

What is the Colorectal Carcinoma Biomarker Panel?

The Colorectal Carcinoma Biomarker Panel evaluates four clinically relevant biomarkers in tumour tissue from patients with confirmed colorectal carcinoma. The results help the treating team assess whether immunotherapy or targeted therapy may be appropriate and identify patients who may need further evaluation for Lynch syndrome. Mismatch repair testing is relevant at initial diagnosis, while HER2, BRAF and KRAS results are particularly useful in treatment planning for metastatic disease.

What the panel evaluates

BiomarkerWhat the result can tell your care team
Mismatch repair (MMR) / microsatellite instability (MSI)MMR immunohistochemistry assesses the tumour’s expression of four proteins: MLH1, PMS2, MSH2 and MSH6. Loss of expression can indicate deficient mismatch repair (dMMR). Molecular MSI testing, when performed, assesses changes in repetitive DNA sequences. A dMMR or MSI-high result may support consideration of immune checkpoint inhibitor therapy and can prompt further evaluation for Lynch syndrome.
HER2 (ERBB2)HER2 immunohistochemistry assesses protein expression in tumour cells. An equivocal result may require in situ hybridization to determine whether the HER2 gene is amplified. A HER2-positive result can help identify patients with metastatic colorectal cancer who may be eligible for HER2-directed therapy.
BRAFThe BRAF V600E variant provides prognostic information and can help guide targeted therapy in metastatic colorectal cancer. In a tumour with loss of MLH1 expression, detection of BRAF V600E also favours a sporadic cause and helps guide further evaluation for Lynch syndrome.
KRASKRAS mutation testing helps determine whether anti-EGFR therapy, such as cetuximab or panitumumab, is appropriate in metastatic colorectal cancer. A wild-type KRAS result alone is insufficient to establish eligibility. Treatment selection requires extended RAS testing that covers both KRAS and NRAS.

Specimen and test requests

Testing uses formalin-fixed, paraffin-embedded (FFPE) tumour tissue from a biopsy or surgical resection. Contact Labtest Zote Diagnostics to confirm specimen submission requirements and assay availability before sending material. Your treating clinician will interpret the findings alongside the pathology report, disease stage and treatment history.

How Long Do the Results Take?

Colorectal Carcinoma Biomarker Panel report takes 4-6 weeks to be ready. A comprehensive report will be sent to you via email and also to your client portal.

How to Request the Colorectal Carcinoma Biomarker Panel

  1. Click the Book Test button to complete the online booking process
  2. Once we receive your booking, we’ll contact you on email / Whatsapp to arrange how to receive the tissue block (physically bring to our office or send
  3. Ensure the tissue block and a copy of the histology report are available.

Need help? Please contact us by clicking WhatsApp Chat button below to speak with our team member

Clinical sources

  1. European Society for Medical Oncology. Metastatic Colorectal Cancer Living Guideline, version 2.0, June 2026.
  2. American Society of Clinical Oncology. Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of the College of American Pathologists Guideline.
  3. ASCP, CAP, AMP and ASCO. Molecular Biomarkers for the Evaluation of Colorectal Carcinoma: Summary of Recommendations.
  4. European Society for Medical Oncology. Pan-Asian adapted ESMO Clinical Practice Guidelines for metastatic colorectal cancer.
  5. U.S. Food and Drug Administration. Tucatinib with trastuzumab for HER2-positive colorectal cancer and encorafenib for BRAF V600E-mutated metastatic colorectal cancer.

Your cart

Loading cart

Secure checkout